FDA Approves Apple Watch for Hypertension Notifications

Apple Watch Introduces Hypertension Notifications

During its recent Awe Dropping event, Apple unveiled an exciting new feature for the Apple Watch: hypertension notifications. This innovative addition is part of the upcoming watchOS 26 update. However, Apple will be rolling out the feature only after receiving the necessary clearance from the US Food and Drug Administration (FDA).

FDA Approval and Anticipated Launch

According to reports from various media outlets, including The Verge, the feature has now secured FDA approval and is expected to launch next week. Apple spokesperson Zaina Khachadourian confirmed this development in a recent statement.

How the Hypertension Notifications Work

As its name implies, the hypertension notification feature alerts users to potential signs of elevated blood pressure. The functionality relies on the optical heart sensor integrated into the Apple Watch, which monitors the heart’s impact on blood vessel responsiveness.

Machine Learning and Clinical Validation

Apple’s advanced machine learning algorithm operates seamlessly in the background, analyzing user data over a 30-day period. If persistent signs of hypertension are identified, the watch will send an alert. To enhance its accuracy, Apple utilized training data from an impressive array of studies involving over 100, 000 participants, with clinical validation performed on more than 2, 000 individuals.

A Global Health Concern

Hypertension poses a significant global health challenge, affecting more than 1.3 billion adults worldwide. Although the Apple Watch may not identify all cases of hypertension, the company anticipates that the feature will alert over 1 million individuals with undiagnosed hypertension within its first year of implementation.

Compatibility and Safety Precautions

The hypertension notifications will be available on the newly launched Apple Watch Ultra 3 and Apple Watch Series 11, and will extend to the Apple Watch Ultra 2 and Apple Watch Series 9 (and later models) as part of the upcoming watchOS 26 update.

This feature will be accessible in over 150 countries and regions, including the United States and the European Union. However, Apple advises that it is not intended for individuals under 22 years of age, those with a prior diagnosis of hypertension, or during pregnancy.

Source&Images